NO20084002L - Peptider og peptid derivater savel som farmasoytiske sammensetninger inneholdende det samme - Google Patents

Peptider og peptid derivater savel som farmasoytiske sammensetninger inneholdende det samme

Info

Publication number
NO20084002L
NO20084002L NO20084002A NO20084002A NO20084002L NO 20084002 L NO20084002 L NO 20084002L NO 20084002 A NO20084002 A NO 20084002A NO 20084002 A NO20084002 A NO 20084002A NO 20084002 L NO20084002 L NO 20084002L
Authority
NO
Norway
Prior art keywords
peg
denotes
residue
well
alkyl
Prior art date
Application number
NO20084002A
Other languages
English (en)
Norwegian (no)
Inventor
Peter Petzelbauer
Rainer Henning
Sonja Reingruber
Original Assignee
Fibrex Medical Res & Dev Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fibrex Medical Res & Dev Gmbh filed Critical Fibrex Medical Res & Dev Gmbh
Publication of NO20084002L publication Critical patent/NO20084002L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO20084002A 2006-02-23 2008-09-19 Peptider og peptid derivater savel som farmasoytiske sammensetninger inneholdende det samme NO20084002L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT3012006 2006-02-23
PCT/AT2007/000095 WO2007095660A1 (fr) 2006-02-23 2007-02-23 Peptides et derives peptidiques ainsi que compositions pharmaceutiques les renfermant

Publications (1)

Publication Number Publication Date
NO20084002L true NO20084002L (no) 2008-11-18

Family

ID=38042580

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084002A NO20084002L (no) 2006-02-23 2008-09-19 Peptider og peptid derivater savel som farmasoytiske sammensetninger inneholdende det samme

Country Status (15)

Country Link
US (3) US7799758B2 (fr)
EP (2) EP2256131A1 (fr)
JP (1) JP2009527502A (fr)
KR (1) KR20090005300A (fr)
CN (1) CN101389653A (fr)
AT (1) ATE513853T1 (fr)
AU (1) AU2007219031B2 (fr)
CA (1) CA2641908A1 (fr)
ES (1) ES2371038T3 (fr)
IL (1) IL193435A0 (fr)
MX (1) MX2008010930A (fr)
NO (1) NO20084002L (fr)
RU (1) RU2008137796A (fr)
WO (1) WO2007095660A1 (fr)
ZA (1) ZA200807028B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2544676A1 (fr) * 2004-06-25 2006-01-05 Fibrex Medical Research & Development Gesmbh Utilisation de peptides derives de la chaine a alpha ou b beta du fibrinogene humain pour le traitement de chocs
US8722623B2 (en) * 2007-09-17 2014-05-13 University Of Maryland, Baltimore Compositions and methods utilizing fibrin beta chain fragments
WO2009096502A1 (fr) * 2008-01-31 2009-08-06 Japan As Represented By President Of National Center Of Neurology And Psychiatry Marqueur pour la dépression et un état déprimé et détection et diagnostic l'utilisant
US7884074B2 (en) 2008-05-15 2011-02-08 Ikaria Development Subsidiary Two, LLC Compounds and methods for prevention and/or treatment of inflammation using the same
US20090286740A1 (en) * 2008-05-15 2009-11-19 Fibrex Medical Research & Development Gmbh Peptides and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
US20090286725A1 (en) * 2008-05-15 2009-11-19 Fibrex Medical Research & Development Gmbh Peptides and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
US8088890B2 (en) * 2008-09-26 2012-01-03 Fibrex Medical Research & Development Gmbh Peptides and peptidomimetic compounds, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
WO2010043444A2 (fr) * 2008-10-15 2010-04-22 Fibrex Medical Research & Development Gmbh Préparation pharmaceutique pour le traitement et/ou la prévention d'une lésion par ischémie/reperfusion et de ses séquelles
US20100152832A1 (en) * 2008-12-12 2010-06-17 Medtronic Vascular, Inc. Apparatus and Methods for Treatment of Aneurysms With Fibrin Derived Peptide B-Beta
US8841257B2 (en) * 2009-04-10 2014-09-23 Board Of Regents, The University Of Texas System Inhibitors of STAT3 and uses thereof
WO2019011879A1 (fr) 2017-07-09 2019-01-17 Rainer Henning Agent thérapeutique pour le traitement du syndrome de fuite capillaire
JP7429032B2 (ja) * 2019-12-24 2024-02-07 学校法人順天堂 間質性肺炎モデル非ヒト動物の作製方法
EP3912679A1 (fr) 2020-05-19 2021-11-24 Johann Wolfgang Goethe-Universität Frankfurt am Main Bbeta pour le traitement de l'endothélite virale

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966848A (en) * 1988-02-08 1990-10-30 The General Hospital Corporation Isolation, purification, characterization, cloning and sequencing of N α-acetyltransferase
US5223421A (en) * 1989-10-25 1993-06-29 The General Hospital Corporation Identification of methionine Nα-acetyltransferase
US5965107A (en) * 1992-03-13 1999-10-12 Diatide, Inc. Technetium-99m labeled peptides for imaging
CA2106079C (fr) * 1991-03-15 2000-04-25 Robert C. Thompson Pegylation de polypeptides
US5688489A (en) * 1995-09-15 1997-11-18 Resolution Pharmaceuticals, Inc. Non-receptor mediated imaging agents
US6323311B1 (en) * 1999-09-22 2001-11-27 University Of Utah Research Foundation Synthesis of insulin derivatives
SI1341819T1 (sl) 2000-12-12 2006-10-31 Fibrex Medical Res & Dev Gmbh Uporaba fibrinskih/fibrinogenskih peptidov in proteinov za pripravo zdravila
DE10314329A1 (de) * 2003-03-28 2004-10-21 Zf Friedrichshafen Ag Antriebsstrang zum Antrieb eines Mobil-Fahrzeugs
EA010016B1 (ru) 2003-05-12 2008-06-30 Афимакс, Инк. Новые модифицированные полиэтиленгликолем соединения и их применение
CA2544676A1 (fr) * 2004-06-25 2006-01-05 Fibrex Medical Research & Development Gesmbh Utilisation de peptides derives de la chaine a alpha ou b beta du fibrinogene humain pour le traitement de chocs
AT502987A1 (de) * 2005-12-23 2007-07-15 Fibrex Medical Res & Dev Gmbh Pharmazeutische zusammensetzung zur behandlung von hämorrhagischem schock und seinen folgeerscheinungen

Also Published As

Publication number Publication date
MX2008010930A (es) 2008-10-29
EP1987062A1 (fr) 2008-11-05
US20100279924A1 (en) 2010-11-04
IL193435A0 (en) 2011-08-01
US7799758B2 (en) 2010-09-21
AU2007219031A1 (en) 2007-08-30
JP2009527502A (ja) 2009-07-30
ZA200807028B (en) 2009-11-25
EP1987062B1 (fr) 2011-06-22
CN101389653A (zh) 2009-03-18
EP2256131A1 (fr) 2010-12-01
AU2007219031B2 (en) 2011-11-03
KR20090005300A (ko) 2009-01-13
CA2641908A1 (fr) 2007-08-30
US20110098442A1 (en) 2011-04-28
ATE513853T1 (de) 2011-07-15
RU2008137796A (ru) 2010-03-27
ES2371038T3 (es) 2011-12-26
US20080039388A1 (en) 2008-02-14
WO2007095660A1 (fr) 2007-08-30

Similar Documents

Publication Publication Date Title
NO20084002L (no) Peptider og peptid derivater savel som farmasoytiske sammensetninger inneholdende det samme
MX2010004297A (es) Antagonistas de glucagon.
NO20092774L (no) HLA-A*1101-begrenset WT1-peptid og farmasoytisk preparat som omfatter dette
WO2005012347A3 (fr) Nouveaux derives de l'insuline
CY1109722T1 (el) Ενδιαμεσες ενωσεις για την παρασκευη της trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,73oxepino[4,5-c]pyrrole
AR061097A1 (es) Procedimiento para sintetizar timosinas
PE20120021A1 (es) Mutantes fgf21
DE502005006284D1 (de) Keratin-bindende polypeptide
PE20140974A1 (es) Compuestos de insulina lispro pegilada
CY1113299T1 (el) Πολυπεπτιδια απροτινινης για τη μεταφορα μιας ενωσης μεσα στον αιματοεγκεφαλικο φραγμο
NO20071369L (no) Antimikrobiske peptider omfattende et arginin- og/eller lysin-inneholdende motiv
DE602006017207D1 (de) Rekombinante n-glykosylierte proteine aus prokaryontischen zellen
MX2011011130A (es) Proteina o peptido de fusion con vida media in vivo incrementada mantenido por liberacion in vivo sostenida, y metodo para incrementar la vida media in vivo usando el mismo.
RS52535B (en) PHARMACEUTICAL MIXTURES CONTAINING ACTIVIN-ACTRIIA ANTAGONISTS AND THEIR USE IN THE PREVENTION OR TREATMENT OF MULTIPLE MYELOMA
DK2162462T3 (da) Cxc-chemokin-receptor-4 (cxcr4) antagonistisk polypeptid
CL2012000063A1 (es) Polipéptido factor ix (fix) o un fragmento del mismo porque comprende la modificación de un aminoácido; vector; célula; método para expresar el polipéptido fix; composición farmacéutica; uso de la composición para tratar enfermedades trombóticas, hemorrágicas y coagulación intravascular diseminada (cid) (div. sol. 1796-07).
RS54215B1 (en) COMPOSITIONS AND PROCEDURES FOR DIAGNOSIS AND TREATMENT OF CANCER
ATE357455T1 (de) Neue effektoren der dipeptidyl peptidase iv zur topischen anwendung
EA200702408A1 (ru) Аналоги глюкагонподобного пептида-2 (glp-2)
DE602006020032D1 (de) Il-21-varianten
AR055179A1 (es) Procedimiento para la amidacion de polipeptidos con aminoacidos de caracter basico c-terminales mediante el uso de endoproteasas especificas
BRPI0718996B8 (pt) método para a preparação de um peptídio da fórmula h-d-?-nal-[cys-tyr-d-trp-lys-val-cys]-thr-nh2 ou h-d-?-nal-cys(acm)-tyr-d-trp-lys-val-cys(acm)-thr
ATE517118T1 (de) Bis-met-histone
ATE506957T1 (de) Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen
MX2010012042A (es) Peptidos, peptidomimeticos y derivados de los mismos, su fabricacion asi como su uso para preparar una composicion farmaceutica terapeutica y/o preventivamente activa.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application